Lista de obras -

A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes

artículo científico publicado en 2011

A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England

artículo científico publicado en 2002

An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making

artículo científico publicado en 2014

Challenges for Drug Repurposing in the COVID-19 Pandemic Era

scientific article published on 06 November 2020

Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia

artículo científico publicado en 2012

Developing tools for the safety specification in risk management plans: lessons learned from a pilot project

artículo científico

European commission consultation on pharmacovigilance

artículo científico publicado en 2008

Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study

artículo científico publicado en 2020

Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti-Infective Agents: A Systematic Literature Review From the ARITMO Project

artículo científico publicado en 2016

Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes

artículo científico publicado en 2006

Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes

artículo científico publicado en 2013

Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database

artículo científico publicado en 2005

How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme

artículo científico publicado en 2013

How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine

scientific article published on 21 November 2020

Hypoglycaemia with pioglitazone: analysis of data from the Prescription-Event Monitoring study

artículo científico publicado en 2010

Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study

artículo científico publicado en 2020

Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes

artículo científico publicado en 2012

Investigation assessing the publicly available evidence supporting postmarketing withdrawals, revocations and suspensions of marketing authorisations in the EU since 2012.

artículo científico publicado en 2018

Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment

artículo científico publicado en 2020

New Postgraduate Qualifications in Pharmacovigilance from the Drug Safety Research Unit in the UK

artículo científico publicado el 1 de enero de 2011

Paediatric postmarketing pharmacovigilance using prescription-event monitoring: comparison of the adverse event profiles of lamotrigine prescribed to children and adults in England

artículo científico publicado en 2010

Paediatric post‐marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adults ⬇️

artículo científico publicado el 23 de febrero de 2011

Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?

artículo científico publicado en 2020

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study

artículo científico publicado en 2005

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

artículo científico publicado en 2005

Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice

scientific article published on 23 July 2020

Real-world efficacy of deep TMS for obsessive-compulsive disorder: Post-marketing data collected from twenty-two clinical sites

artículo científico publicado en 2020

Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England

artículo científico publicado en 2003

Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment

artículo científico publicado en 2020

Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England

artículo científico publicado en 2016

Safety profile of modafinil across a range of prescribing indications, including off-label use, in a primary care setting in England: results of a modified prescription-event monitoring study

artículo científico

The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK

scientific article published on 01 March 2020

The safety of H1N1 vaccine in children in Saudi Arabia: a cohort study using modern technology in a developing country

artículo científico publicado en 2012

Lista de obras de

A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes

A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England

An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making

Challenges for Drug Repurposing in the COVID-19 Pandemic Era

Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia

Developing tools for the safety specification in risk management plans: lessons learned from a pilot project

European commission consultation on pharmacovigilance

Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study

Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti-Infective Agents: A Systematic Literature Review From the ARITMO Project

Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes

Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes

Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database

How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme

How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine

Hypoglycaemia with pioglitazone: analysis of data from the Prescription-Event Monitoring study

Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study

Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes

Investigation assessing the publicly available evidence supporting postmarketing withdrawals, revocations and suspensions of marketing authorisations in the EU since 2012.

Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment

New Postgraduate Qualifications in Pharmacovigilance from the Drug Safety Research Unit in the UK

Paediatric postmarketing pharmacovigilance using prescription-event monitoring: comparison of the adverse event profiles of lamotrigine prescribed to children and adults in England

Paediatric post‐marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adults ⬇️

Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice

Real-world efficacy of deep TMS for obsessive-compulsive disorder: Post-marketing data collected from twenty-two clinical sites

Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England

Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment

Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England

Safety profile of modafinil across a range of prescribing indications, including off-label use, in a primary care setting in England: results of a modified prescription-event monitoring study

The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK

The safety of H1N1 vaccine in children in Saudi Arabia: a cohort study using modern technology in a developing country